世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

臨床意思決定支援システム（CDSS）市場：コンポーネント別（サービス、ソフトウェア）、デリバリー別（オンプレミス、クラウド）、製品別（スタンドアロン、統合）、アプリケーション別（先端、治療、診断）、インタラクティビティ別（アクティブ、パッシブ） - 2028年までの世界予測


Clinical Decision Support Systems (CDSS) Market by Component (Services, Software), Delivery (On-premise, Cloud), Product (Standalone, Integrated), Application (Advanced, Therapeutic, Diagnostic), Interactivity (Active, Passive) - Global Forecasts to 2028

世界の臨床意思決定支援システム（CDSS）市場は、予測期間中に年平均成長率7.5%で、2023年の17億米ドルから2028年には25億米ドルに達すると予測されている。この市場の成長は主に、HITソリューションの採用を促進... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 図表数 言語
MarketsandMarkets
マーケッツアンドマーケッツ 		2023年9月12日 US$4,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		279 269 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

世界の臨床意思決定支援システム（CDSS）市場は、予測期間中に年平均成長率7.5%で、2023年の17億米ドルから2028年には25億米ドルに達すると予測されている。この市場の成長は主に、HITソリューションの採用を促進するための政府規制やイニシアチブの実施、CDSS対応EHRの採用増加、利害関係者間の連携やパートナーシップの拡大、投薬ミスの発生率の上昇、mHealthやビッグデータツールの開発によってもたらされる。
しかし、CDSS導入のための投資要件が高いこと、相互運用性が不十分であること、データセキュリティへの懸念が高まっていることなどが、予測期間中の同市場の成長を抑制する要因になると予想される。


"ソフトウェア分野は2023年から2028年にかけて最も高い成長率が見込まれる"
コンポーネント別に見ると、臨床意思決定支援システム市場はサービス、ソフトウェア、ハードウェアに分けられる。2022年の同市場では、サービス分野が最大のシェアを占めている。複雑なソフトウェアの導入、統合、ソフトウェアの相互運用性により、大規模なトレーニングやアップグレードが必要となるため、サービスに対する需要は今後数年間で急拡大する見込みである。

"オンプレミスCDSSセグメントが2023年に臨床意思決定支援システム市場で最大のシェアを占めると推定される"
提供形態別に見ると、臨床意思決定支援システム市場はオンプレミス型とクラウド型に分かれる。2023年には、オンプレミス型CDSSセグメントが臨床意思決定支援システム市場で最大のシェアを占めると予測されている。このモデルで発生する資本費用や運用コストの低さ、拡張性、柔軟性、低コストなどの要因が、市場成長の原動力となっている。

"2022年、従来型CDSS分野が世界の臨床意思決定支援システム市場で最大のシェアを占める（用途別）"
用途別に見ると、臨床意思決定支援システム市場は従来型CDSSと先進型CDSSに分けられる。2022年には、従来型CDSS分野が最大シェアを占めた。医療機関がポイントオブケアで介護者にガイダンスやリマインダーを提供するために従来型の意思決定支援システムを採用していることなどが市場成長を促進している。

"2022年、統合型CDSS分野が世界の臨床意思決定支援システム市場で最大シェアを占める"
製品別に見ると、臨床意思決定支援システム市場は統合型CDSSとスタンドアロン型CDSSに分けられる。統合型CDSSセグメントが2022年の市場で最大のシェアを占めた。このセグメントの大きなシェアは、医療従事者による投薬ミスの減少や、健康アウトカムとケアの質を改善するための統合型CDSSの利用増加によるものと考えられる。
「治療用CDSS分野は2023年から2028年にかけて最も高いCAGRで成長する見込みである。
臨床意思決定支援システム市場は、タイプ別に治療用CDSSと診断用CDSSに分けられる。2022年には、治療用CDSS分野がこの市場を支配した。この分野の成長率が最も高いのは、治療用CDSSが高い計算能力と豊富な医療知識を備えているため、臨床医が（患者固有の医療事実に基づく）情報に基づいた治療上の意思決定を行うことが可能であることなどが要因として挙げられる。
"モデル別では、知識ベースCDSSセグメントが世界の臨床意思決定支援システム市場で最大のシェアを占める"
臨床意思決定支援システム市場は、知識ベースCDSSと非知識ベースCDSSの2つの主要モデルに分類される。2022年には、知識ベースCDSSセグメントが最大の市場シェアを占めた。この特定のセグメントは、予測期間を通じて大幅な成長を遂げると予測されている。この成長は、慢性疾患の有病率の増加とともに、個別化医療とエビデンスに基づく医療へのニーズの高まりに起因している。

"アクティブCDSSセグメントは予測期間中最高のCAGRで成長すると予測される"

臨床意思決定支援システム市場は、双方向性レベルに基づいてアクティブCDSSとパッシブCDSSに分類できる。2022年には、アクティブCDSS分野が市場シェアを独占し、予測期間中に最も急速な成長率を示すと予測されている。EHR、CDSS、CPOEを含む臨床ITソリューションの育成を目的とした政府の強力な取り組みと、医療費抑制の必要性の高まりが、この特定市場セグメントの発展に寄与している。

「2022年の臨床意思決定支援システムの世界市場で最大のシェアを占めるのは入院患者環境である。
セッティングの観点から、臨床意思決定支援システム市場は入院患者と外来患者のセッティングに分類される。2022年には、入院患者の設定がCDSS市場シェアを独占した。この優位性は、入院患者環境における広範な患者データの実質的な蓄積と分析に起因しており、その結果、統合医療ITモジュールの取り込みが加速している。

「2023年、北米が臨床意思決定支援システム市場を支配する"
2022年の世界の臨床意思決定支援システム市場では、北米が最大のシェアを占めた。
主要な業界参加者の存在、CDSSの導入を支援する規制上の指令、米国とカナダにおける投薬ミスの増加などの要素が、こうした傾向に寄与している。
予測では、予測期間を通じてアジア太平洋地域が最も大きな年平均成長率（CAGR）を記録する。これは、慢性疾患の有病率の上昇や、アジア新興国に対する多様な市場関係者の関心の高まりなどの要因によるものである。これらの要因は、アジア太平洋地域における臨床意思決定支援システム市場の拡大を促進すると予想される。


供給側一次インタビューの内訳（企業タイプ別、呼称別、地域別
- 企業タイプ別ティア1（45％）、ティア2（35％）、ティア3（20）
- 役職別Cレベル(26%)、ディレクターレベル(17%)、その他(57%)
- 地域別北米(40%)、欧州(20%)、アジア太平洋(30%)、中南米(6%)、MEA(4%)

臨床意思決定支援システム市場に参入している主な企業は、Wolters Kluwer N.V.（オランダ）、Oracle（米国）、Merative（米国）、Change Healthcare（米国）、Veradigm Inc.（米国）、athenahealth（米国）、Epic Systems Corporation（米国）、Elsevier B.V.（オランダ）、Zynx Health（米国）、Koninklijke Philips N.V.（オランダ）、Medical Information Technology, Inc.(米国）、NextGen Healthcare, Inc.（米国）、CureMD Healthcare（米国）、Siemens Healthineers（ドイツ）、EBSCO Information Services（米国）、GE HealthCare（米国）、eClinicalWorks（米国）、The Medical Algorithms Company（英国）、RAMPmedical（ドイツ）、Hera-MI（フランス）、CareCloud, Inc.（米国）、VisualDx（米国）、Premier, Inc.（米国）、First Databank, Inc.（米国）、Strata Decision Technology（米国）。
調査範囲
- 臨床意思決定支援システム市場を、コンポーネント、提供形態、製品、モデル、双方向性レベル、用途、設定、タイプ、地域に基づいて調査しています。
- 市場成長に影響を与える要因（促進要因、阻害要因、機会、課題など）を分析しています。
- 利害関係者向けに市場の機会と課題を評価し、市場リーダー向けに競争状況の詳細を提供します。
- 臨床意思決定支援システム市場全体の成長動向、展望、貢献に関してミクロ市場を調査しています。
- 主要4地域に関して市場セグメントの収益を予測しています。
レポート購入の理由
本レポートは、既存企業だけでなく、新規参入企業や中小企業にとっても、市場の動向を把握する上で有益であり、ひいては市場シェアを拡大する上で役立ちます。本レポートを購入される企業は、以下の戦略のいずれか、または任意の組み合わせを使用して、市場での地位を強化することができます。

本レポートでは、以下のポイントに関する洞察を提供しています：
 主な促進要因（HCITソリューションの採用を促進するための政府規制およびイニシアチブの実施、CDSS対応EHRの採用増加、利害関係者間の協力およびパートナーシップの拡大、投薬ミスの発生率の増加、ビッグデータおよびmhealthツールの開発）、阻害要因（クラウドベースのCDSSに関連するデータセキュリティの懸念、不十分な相互運用性）、機会（新興市場の成長可能性、ソーシャルメディアとの統合、技術進歩の高まり）、課題（CDSSインフラ導入のための高額投資の要件、医療業界における熟練IT専門家の不足）に関する分析。

- 市場への浸透：臨床意思決定支援システムの世界市場におけるトップ企業が提供する製品ポートフォリオに関する包括的情報。当レポートでは、この市場をコンポーネント別、提供形態別、製品別、モデル別、双方向性レベル別、用途別、設定別、タイプ別に分析しています。
- サービスの強化/革新：臨床意思決定支援システムの世界市場における今後の動向に関する詳細な洞察
- 市場開発：コンポーネント、配信モード、製品、モデル、双方向性レベル、用途、設定、タイプ別の有利な新興市場に関する包括的な情報。
- 市場の多様化：臨床判断支援システムの世界市場における新サービスやサービス強化、成長地域、最近の動向、投資などに関する詳細な情報を提供します。
- 競合評価：臨床意思決定支援システムの世界市場における主要企業の市場シェア、成長戦略、製品提供、企業評価象限、能力を詳細に評価します。

ページTOPに戻る


目次

1 INTRODUCTION 35
1.1 STUDY OBJECTIVES 35
1.2 MARKET DEFINITION 35
1.2.1 INCLUSIONS AND EXCLUSIONS 36
1.3 MARKET SCOPE 37
1.3.1 MARKETS COVERED 37
FIGURE 1 CDSS MARKET SEGMENTATION 37
1.3.2 REGIONS COVERED 37
1.3.3 YEARS CONSIDERED 38
1.4 CURRENCY CONSIDERED 38
1.5 MAJOR STAKEHOLDERS 38
1.6 SUMMARY OF CHANGES 39
1.7 RECESSION IMPACT 39
2 RESEARCH METHODOLOGY 40
2.1 RESEARCH DATA 40
FIGURE 2 RESEARCH DESIGN 40
2.1.1 SECONDARY DATA 41
2.1.1.1 Key data from secondary sources 42
2.1.2 PRIMARY RESEARCH 42
FIGURE 3 PRIMARY SOURCES 43
2.1.2.1 Key data from primary sources 44
2.1.2.2 Key industry insights 44
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 45
2.2 MARKET SIZE ESTIMATION 45
FIGURE 5 HYPOTHESIS BUILDING 46
2.3 MARKET SIZE ESTIMATION METHODOLOGY 46
2.3.1 APPROACH 1: REVENUE SHARE ANALYSIS 46
FIGURE 6 RESEARCH METHODOLOGY: MARKET ESTIMATION 47
2.3.2 APPROACH 2: DEMAND-SIDE ANALYSIS 47
FIGURE 7 APPROACH 2: DEMAND SIDE ANALYSIS 48
2.3.3 APPROACH 3: BOTTOM-UP AND SEGMENTAL EXTRAPOLATION 48
FIGURE 8 APPROACH 3: BOTTOM-UP AND SEGMENTAL EXTRAPOLATION 49
FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50
FIGURE 10 CLINICAL DECISION SUPPORT SYSTEMS MARKET: CAGR PROJECTION ANALYSIS 50
2.4 MARKET DATA ESTIMATION AND TRIANGULATION 52
FIGURE 11 DATA TRIANGULATION METHODOLOGY 52
2.5 STUDY ASSUMPTIONS 53
2.6 RISK ASSESSMENT 54
TABLE 1 RISK ASSESSMENT ANALYSIS 54
2.7 LIMITATIONS 54
2.7.1 SCOPE-RELATED LIMITATIONS 54
2.7.2 METHODOLOGY-RELATED LIMITATIONS 54
2.8 RECESSION IMPACT ANALYSIS 54
3 EXECUTIVE SUMMARY 56
FIGURE 12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2023 VS. 2028 (USD MILLION) 56
FIGURE 13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 57
FIGURE 14 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 57
FIGURE 15 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2023 VS. 2028 (USD MILLION) 58
FIGURE 16 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 59
FIGURE 17 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2023 VS. 2028 (USD MILLION) 59
FIGURE 18 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2023 VS. 2028 (USD MILLION) 60
FIGURE 19 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2023 VS. 2028 (USD MILLION) 61
FIGURE 20 GEOGRAPHICAL SNAPSHOT OF CLINICAL DECISION SUPPORT SYSTEMS MARKET 62
4 PREMIUM INSIGHTS 63
4.1 CLINICAL DECISION SUPPORT SYSTEMS MARKET OVERVIEW 63
FIGURE 21 INCREASING GOVERNMENT REGULATIONS FOR IMPLEMENTATION OF HCIT SOLUTIONS TO DRIVE MARKET 63
4.2 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT AND COUNTRY 64
FIGURE 22 INTEGRATED CDSS SEGMENT DOMINATED US MARKET IN 2022 64
4.3 CLINICAL DECISION SUPPORT SYSTEMS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 64
FIGURE 23 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 64
4.4 CLINICAL DECISION SUPPORT SYSTEMS MARKET: REGIONAL MIX 65
FIGURE 24 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 65
4.5 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DEVELOPED VS. EMERGING ECONOMIES 65
FIGURE 25 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD 65
 
5 MARKET OVERVIEW 66
5.1 INTRODUCTION 66
5.2 MARKET DYNAMICS 66
FIGURE 26 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 66
5.2.1 DRIVERS 67
5.2.1.1 Increasing government regulations for implementation of HCIT solutions 67
5.2.1.2 Growing adoption of CDSS-enabled EHRs 68
5.2.1.3 Rising incidence of medication errors 69
5.2.2 RESTRAINTS 69
5.2.2.1 Data security concerns in cloud-based CDSS 69
5.2.2.2 Inadequate interoperability for patient management solutions 69
5.2.3 OPPORTUNITIES 70
5.2.3.1 Development of big data and mHealth tools 70
5.2.3.2 High growth potential of emerging economies 70
5.2.3.3 Rising technological advancements 71
5.2.4 CHALLENGES 72
5.2.4.1 High capital investments for CDSS infrastructure 72
5.2.4.2 Shortage of skilled IT professionals 72
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 72
FIGURE 27 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR CLINICAL DECISION SUPPORT SYSTEMS MARKET 72
5.4 VALUE CHAIN ANALYSIS 73
FIGURE 28 CLINICAL DECISION SUPPORT SYSTEMS MARKET: VALUE CHAIN ANALYSIS 73
5.5 CASE STUDY ANALYSIS 73
5.5.1 IMPROVING PATIENT OUTCOMES 73
TABLE 2 CASE 1: RISING FOCUS ON IMPROVING PATIENT SAFETY 73
5.5.2 KNOWLEDGE ANALYZER DELIVERS ADVANCED CLINICAL EXPERIENCE 74
TABLE 3 CASE 2: RISING NEED TO STREAMLINE PATIENT OUTCOMES 74
5.5.3 ENHANCING PHYSICIAN EFFICIENCY 74
TABLE 4 CASE 3: RISING NEED TO IMPROVE RESPONSE TIME AND PHYSICIAN EFFICIENCY IN HEALTHCARE FACILITIES 74
5.5.4 INCREASING EFFICIENCY AND HEALTHCARE OUTCOMES WITH AI 75
TABLE 5 CASE 4: RISING FOCUS ON ENHANCING EFFICIENCY AND VALUE-BASED CARE WITH AI-POWERED CDSS 75
5.6 ECOSYSTEM ANALYSIS 75
FIGURE 29 CLINICAL DECISION SUPPORT SYSTEM MARKET: ECOSYSTEM ANALYSIS 75
5.7 TECHNOLOGY ANALYSIS 76
TABLE 6 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS 76
5.8 TARIFF AND REGULATORY ANALYSIS 78
5.8.1 TARIFF FOR CDSS HARDWARE 78
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 7 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 8 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81
TABLE 10 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81
5.8.3 NORTH AMERICA 82
5.8.3.1 Federal Food, Drug, and Cosmetic Act (FD&C Act) 82
5.8.3.2 Health Insurance Portability and Accountability Act (HIPAA) 83
5.8.3.3 Affordable Care Act, 2010 83
5.8.3.4 Health Information Technology for Economic and Clinical Health Act, 2009 (HITECH) 83
5.8.3.5 Consumer Privacy Protection Act, 2017 83
5.8.4 EUROPE 84
5.8.4.1 General Data Protection Regulation (GDPR), European Union (EU) 84
5.8.4.2 EU Cybersecurity Act 84
5.8.5 ASIA PACIFIC 84
5.8.5.1 China’s Cyber Security Law (CSL) 84
5.8.6 REST OF THE WORLD 84
5.8.6.1 Protection of Personal Information Act 84
5.8.6.2 Private cloud computing regulatory framework 84
5.9 PORTER'S FIVE FORCES ANALYSIS 85
TABLE 11 CLINICAL DECISION SUPPORT SYSTEMS MARKET: PORTER’S FIVE FORCES ANALYSIS 85
5.9.1 THREAT OF NEW ENTRANTS 85
5.9.2 THREAT OF SUBSTITUTES 85
5.9.3 BARGAINING POWER OF SUPPLIERS 86
5.9.4 BARGAINING POWER OF BUYERS 86
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 86
5.10 INDUSTRY TRENDS 86
5.10.1 GROWING APPLICATIONS OF AI IN CDSS 86
5.10.2 INCREASING FOCUS ON MOBILE & CLOUD-BASED SOLUTIONS 87
5.10.3 RISING NEED FOR INTEROPERABILITY & INTEGRATION OF HCIT SOLUTIONS 87
5.10.4 GRADUAL SHIFT OF ACCOUNTABILITY FROM PAYERS TO PROVIDERS 88
5.10.5 INCREASING DEMAND FOR VALUE-BASED HEALTHCARE 88
5.11 BUSINESS MODELS 89
FIGURE 30 BENEFITS OF HYBRID BUSINESS MODELS 90
5.12 PRICING ANALYSIS 90
5.12.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT 90
FIGURE 31 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT 91
5.12.2 AVERAGE SELLING PRICE TREND, BY REGION 91
TABLE 12 AVERAGE SELLING PRICE TREND, BY REGION 92
5.13 PATENT ANALYSIS 92
5.13.1 PATENT PUBLICATION TRENDS FOR CLINICAL DECISION SUPPORT SYSTEMS 92
FIGURE 32 PATENT PUBLICATION TRENDS (JANUARY 2011–JUNE 2023) 93
5.13.2 INSIGHTS INTO JURISDICTION AND TOP APPLICANT ANALYSIS 93
FIGURE 33 CLINICAL DECISION SUPPORT SYSTEMS MARKET: TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR PATENTS (JANUARY 2011–AUGUST 2023) 94
5.13.3 LIST OF PATENTS/PATENT APPLICATIONS FOR CDSS 94
5.14 KEY CONFERENCES AND EVENTS 96
TABLE 13 CLINICAL DECISION SUPPORT SYSTEMS: DETAILED LIST OF CONFERENCES AND EVENTS (2023–2024) 96
5.15 TRADE ANALYSIS 96
5.15.1 TRADE ANALYSIS FOR CLINICAL DECISION SUPPORT SYSTEM HARDWARE 96
FIGURE 34 IMPORTS OF PRODUCTS UNDER HSN CODE: 901890, BY COUNTRY, 2022 (USD THOUSAND) 97
FIGURE 35 EXPORTS OF PRODUCTS UNDER HSN CODE: 901890, BY COUNTRY, 2022 (USD THOUSAND) 97
5.16 KEY STAKEHOLDERS AND BUYING CRITERIA 98
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS 98
FIGURE 36 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 98
TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY TYPE (%) 98
5.16.2 BUYING CRITERIA 99
FIGURE 37 CLINICAL DECISION SUPPORT SYSTEMS: KEY BUYING CRITERIA, BY COMPONENT 99
TABLE 15 BUYING CRITERIA FOR COMPONENTS, BY RANK 99
6 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT 100
6.1 INTRODUCTION 101
TABLE 16 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 101
6.2 SERVICES 101
6.2.1 RECURRING REQUIREMENT TO DRIVE MARKET 101
TABLE 17 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 102
6.3 SOFTWARE 103
6.3.1 USE OF EMR-/EHR-INTEGRATED CDSS TO PROPEL MARKET 103
TABLE 18 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION) 103
6.4 HARDWARE 104
6.4.1 FREQUENT UPGRADES FOR OPTIMAL USE TO SUPPORT MARKET GROWTH 104
TABLE 19 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION) 104
7 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT 105
7.1 INTRODUCTION 106
TABLE 20 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 106
7.2 INTEGRATED CDSS 106
7.2.1 INTEGRATION WITH EHRS AND RAPID ACCESS TO PATIENT RECORDS TO DRIVE MARKET 106
TABLE 21 INTEGRATED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 107
7.3 STANDALONE CDSS 108
7.3.1 INTEROPERABILITY ISSUES WITH CPOE AND EHR TO RESTRAIN MARKET 108
TABLE 22 STANDALONE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 108
8 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE 109
8.1 INTRODUCTION 110
TABLE 23 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 110
8.2 THERAPEUTIC CDSS 110
8.2.1 SEAMLESS INTEGRATION INTO CLINICAL WORKFLOWS TO DRIVE MARKET 110
TABLE 24 THERAPEUTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 111
8.3 DIAGNOSTIC CDSS 111
8.3.1 USE OF ALGORITHMS FOR EFFECTIVE REAL-TIME DIAGNOSIS TO SUPPORT MARKET GROWTH 111
TABLE 25 DIAGNOSTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL 113
9.1 INTRODUCTION 114
TABLE 26 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 114
9.2 KNOWLEDGE-BASED CDSS 114
9.2.1 DEPLOYS CONDITIONAL LOGIC FOR DECISION-MAKING AND PROBLEM ANALYSIS 114
TABLE 27 KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115
9.3 NON-KNOWLEDGE-BASED CDSS 115
9.3.1 IMPLEMENTS ML AND AI TO EXPAND USER-DEFINED KNOWLEDGE BASE 115
TABLE 28 NON-KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 116
10 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE 117
10.1 INTRODUCTION 118
TABLE 29 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 118
10.2 ON-PREMISE CDSS 118
10.2.1 LOWER RISK OF DATA BREACH AND ABILITY TO CHOOSE MULTIPLE VENDORS TO DRIVE MARKET 118
TABLE 30 ON-PREMISE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 119
10.3 CLOUD-BASED CDSS 119
10.3.1 FLEXIBLE AND SCALABLE FEATURES TO PROPEL MARKET 119
TABLE 31 CLOUD-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
11 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION 121
11.1 INTRODUCTION 122
TABLE 32 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 122
11.2 CONVENTIONAL CDSS 122
11.2.1 ABILITY TO PROVIDE DIAGNOSTIC ASSISTANCE AND PRESCRIPTION DECISION SUPPORT TO DRIVE MARKET 122
TABLE 33 CONVENTIONAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
11.3 ADVANCED CDSS 123
11.3.1 REAL-TIME EVIDENCE AND PROTOCOL VALIDATION BENEFITS TO PROPEL MARKET 123
TABLE 34 ADVANCED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL 125
12.1 INTRODUCTION 126
TABLE 35 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 126
12.2 ACTIVE CDSS 126
12.2.1 ABILITY TO ENABLE OPTIMAL DECISION-MAKING WITH MINIMAL ERRORS TO DRIVE MARKET 126
TABLE 36 ACTIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 127
12.3 PASSIVE CDSS 127
12.3.1 MINIMAL DISRUPTION TO WORKFLOWS TO SUPPORT MARKET GROWTH 127
TABLE 37 PASSIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 128
13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING 129
13.1 INTRODUCTION 130
TABLE 38 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 130
13.2 INPATIENT SETTINGS 130
13.2.1 GROWING FOCUS ON IMPROVING HEALTHCARE OPERATIONS IN HOSPITALS TO PROPEL MARKET 130
TABLE 39 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR INPATIENT SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION) 131
13.3 AMBULATORY CARE SETTINGS 131
13.3.1 RISING NEED TO CURB HEALTHCARE COSTS TO DRIVE MARKET 131
TABLE 40 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR AMBULATORY CARE SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION) 132
14 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION 133
14.1 INTRODUCTION 134
TABLE 41 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 134
14.2 NORTH AMERICA 134
FIGURE 38 NORTH AMERICA: CDSS MARKET SNAPSHOT 135
TABLE 42 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 43 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 136
TABLE 44 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 136
TABLE 45 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 136
TABLE 46 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 137
TABLE 47 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 137
TABLE 48 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 137
TABLE 49 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 138
TABLE 50 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 138
14.2.1 US 138
14.2.1.1 Growing focus on value-based care to drive market 138
TABLE 51 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 139
TABLE 52 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 140
TABLE 53 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 140
TABLE 54 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 140
TABLE 55 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 141
TABLE 56 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 141
TABLE 57 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 141
TABLE 58 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 142
14.2.2 CANADA 142
14.2.2.1 Rising need to curb healthcare costs to propel market 142
TABLE 59 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 143
TABLE 60 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 143
TABLE 61 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 143
TABLE 62 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 144
TABLE 63 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 144
TABLE 64 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 144
TABLE 65 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 145
TABLE 66 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 145
14.2.3 NORTH AMERICA: RECESSION IMPACT 145
14.3 EUROPE 146
TABLE 67 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 68 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 146
TABLE 69 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 147
TABLE 70 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 147
TABLE 71 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 72 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 148
TABLE 73 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 148
TABLE 74 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 148
TABLE 75 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 149
14.3.1 GERMANY 149
14.3.1.1 Favorable government support for adoption of EMRs to propel market 149
TABLE 76 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 150
TABLE 77 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 150
TABLE 78 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 150
TABLE 79 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 151
TABLE 80 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 151
TABLE 81 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 151
TABLE 82 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 152
TABLE 83 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 152
14.3.2 UK 152
14.3.2.1 Rising establishment of healthcare facilities to fuel market 152
TABLE 84 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 153
TABLE 85 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 153
TABLE 86 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 154
TABLE 87 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 154
TABLE 88 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 154
TABLE 89 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 155
TABLE 90 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 155
TABLE 91 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 155
14.3.3 FRANCE 156
14.3.3.1 Robust interoperability for EHR systems to drive market 156
TABLE 92 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 156
TABLE 93 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 157
TABLE 94 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 157
TABLE 95 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 157
TABLE 96 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 158
TABLE 97 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 158
TABLE 98 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 158
TABLE 99 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 159
14.3.4 ITALY 159
14.3.4.1 Rising need for evidence-based CDSS to drive market 159
TABLE 100 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 159
TABLE 101 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 160
TABLE 102 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 160
TABLE 103 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 160
TABLE 104 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 161
TABLE 105 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 161
TABLE 106 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 161
TABLE 107 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 162
14.3.5 SPAIN 162
14.3.5.1 Growing focus on improving patient outcomes to support market growth 162
TABLE 108 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 162
TABLE 109 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 163
TABLE 110 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 163
TABLE 111 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 112 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 164
TABLE 113 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 164
TABLE 114 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 164
TABLE 115 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 165
14.3.6 REST OF EUROPE 165
TABLE 116 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 165
TABLE 117 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 166
TABLE 118 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 166
TABLE 119 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 166
TABLE 120 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 167
TABLE 121 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 167
TABLE 122 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 167
TABLE 123 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 168
14.3.7 EUROPE: RECESSION IMPACT 168
14.4 ASIA PACIFIC 169
FIGURE 39 ASIA PACIFIC: CDSS MARKET SNAPSHOT 170
TABLE 124 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 125 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 171
TABLE 126 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 171
TABLE 127 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 171
TABLE 128 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 129 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 172
TABLE 130 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 172
TABLE 131 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 173
TABLE 132 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 173
14.4.1 JAPAN 173
14.4.1.1 Rising need to digitize patient records to propel market 173
TABLE 133 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 174
TABLE 134 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 174
TABLE 135 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 174
TABLE 136 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 137 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 175
TABLE 138 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 175
TABLE 139 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 176
TABLE 140 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 176
14.4.2 CHINA 176
14.4.2.1 Established healthcare reforms for EMR solutions to drive market 176
TABLE 141 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 177
TABLE 142 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 177
TABLE 143 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 178
TABLE 144 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 145 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 178
TABLE 146 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 179
TABLE 147 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 179
TABLE 148 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 179
14.4.3 INDIA 180
14.4.3.1 Rising adoption of telemedicine to support market growth 180
TABLE 149 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 180
TABLE 150 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 180
TABLE 151 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 181
TABLE 152 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 153 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 181
TABLE 154 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 182
TABLE 155 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 182
TABLE 156 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 182
14.4.4 REST OF ASIA PACIFIC 183
TABLE 157 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 183
TABLE 158 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 184
TABLE 159 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 184
TABLE 160 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 161 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 185
TABLE 162 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 185
TABLE 163 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 185
TABLE 164 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 186
14.4.5 ASIA PACIFIC: RECESSION IMPACT 186
14.5 REST OF THE WORLD 186
TABLE 165 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 186
TABLE 166 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 187
TABLE 167 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 187
TABLE 168 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 187
TABLE 169 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 170 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 188
TABLE 171 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 188
TABLE 172 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 189
TABLE 173 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 189
14.5.1 LATIN AMERICA 189
14.5.1.1 Developments in healthcare infrastructure to support market growth 189
TABLE 174 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 190
TABLE 175 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 190
TABLE 176 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 190
TABLE 177 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 178 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 191
TABLE 179 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 191
TABLE 180 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 192
TABLE 181 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 192
14.5.2 MIDDLE EAST & AFRICA 192
14.5.2.1 Increasing investments in HCIT solutions to propel market 192
TABLE 182 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 193
TABLE 183 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 193
TABLE 184 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 193
TABLE 185 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 194
TABLE 186 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 194
TABLE 187 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 194
TABLE 188 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 195
TABLE 189 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 195
14.5.3 REST OF THE WORLD: RECESSION IMPACT 195
15 COMPETITIVE LANDSCAPE 196
15.1 OVERVIEW 196
15.2 STRATEGIES ADOPTED BY KEY PLAYERS 196
TABLE 190 CLINICAL DECISION SUPPORT SYSTEMS MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS 197
15.3 REVENUE SHARE ANALYSIS OF LEADING MARKET PLAYERS 198
FIGURE 40 REVENUE SHARE ANALYSIS OF KEY PLAYERS 198
15.4 MARKET SHARE ANALYSIS 199
FIGURE 41 MARKET SHARE ANALYSIS, BY KEY PLAYER (2022) 199
15.5 COMPANY EVALUATION MATRIX 200
15.5.1 STARS 200
15.5.2 EMERGING LEADERS 201
15.5.3 PERVASIVE PLAYERS 201
15.5.4 PARTICIPANTS 201
15.5.5 COMPANY FOOTPRINT 201
TABLE 191 CLINICAL DECISION SUPPORT SYSTEMS MARKET: COMPANY FOOTPRINT OF KEY PLAYERS 201
TABLE 192 CLINICAL DECISION SUPPORT SYSTEMS MARKET: APPLICATION & PRODUCT FOOTPRINT OF KEY PLAYERS 202
TABLE 193 CLINICAL DECISION SUPPORT SYSTEMS MARKET: REGIONAL FOOTPRINT OF KEY PLAYERS 202
FIGURE 42 CLINICAL DECISION SUPPORT SYSTEMS MARKET: COMPANY EVALUATION MATRIX (2022) 203
15.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES 204
15.6.1 PROGRESSIVE COMPANIES 204
15.6.2 RESPONSIVE COMPANIES 204
15.6.3 DYNAMIC COMPANIES 204
15.6.4 STARTING BLOCKS 204
FIGURE 43 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022) 205
15.6.4.1 COMPETITIVE BENCHMARKING 206
TABLE 194 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 206
TABLE 195 CLINICAL DECISION SUPPORT SYSTEMS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (STARTUPS/SMES) 207
15.7 COMPETITIVE SITUATIONS AND TRENDS 207
TABLE 196 CLINICAL DECISION SUPPORT SYSTEMS MARKET: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS (JANUARY 2020–AUGUST 2023) 208
15.7.1 DEALS 210
TABLE 197 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DEALS (JANUARY 2020–AUGUST 2023) 210
15.7.2 OTHER DEVELOPMENTS 212
TABLE 198 CLINICAL DECISION SUPPORT SYSTEMS MARKET: OTHER DEVELOPMENTS (JANUARY 2020–AUGUST 2023) 212

　

ページTOPに戻る


　

Summary

The global clinical decision support systems (CDSS) market is projected to reach USD 2.5 billion by 2028 from USD 1.7 billion in 2023, at a CAGR of 7.5% during the forecast period. The growth of this market is primarily driven by the implementation of government regulations and initiatives to promote the adoption of HIT solutions, increasing adoption of CDSS-enabled EHRs, growing collaborations and partnerships between stakeholders, rising incidence of medication errors, and the development mHealth and big data tools.
However, high investment requirements for the implementation of CDSS and inadequate interoperability coupled with rising data security concerns are factors expected to restrain the growth of this market during the forecast period.


“Software segment is expected to grow at the highest rate from 2023 to 2028”
By component, the clinical decision support systems market is divided into services, software, and hardware. The services segment accounted for the largest share of this market in 2022 The demand for services is expected to grow rapidly in the coming years due to the introduction of complex software, integration, and software interoperability, which requires extensive training and upgrades.

“The On-premise CDSS segment is estimated to account for the largest share of the Clinical decision support systems market in 2023”
By delivery mode, the clinical decision support systems market is divided into on-premise and cloud-based modes. In 2023, the on-premise CDSS segment is projected to hold the largest share of the clinical decision support systems market.Factors such as lower capital expenses and operational costs incurred in this model, together with its scalability, flexibility, and low-cost are driving the market growth.

“In 2022, conventional CDSS segment accounted for the largest share of the global Clinical decision support systems market, by application”
By application, the clinical decision support systems market is divided into conventional CDSS and advanced CDSS. The conventional CDSS segment accounted for the largest share of the market in 2022. Factors such as healthcare organizations are adopting conventional decision support systems to provide guidance and reminders to caregivers at the point-of-care are driving the market growth.

“In 2022, Integrated CDSS segment accounted for the largest share of the global Clinical decision support systems market”
By product, the clinical decision support systems market is divided into integrated CDSS and standalone CDSS. The integrated CDSS segment accounted for the largest share of the market in 2022. The large share of this segment can be attributed to the reduce medication errors by healthcare providers and increased usage of integrated CDSS to improve the health outcomes and quality of care .
“The therapeutic CDSS segment is expected to grow with the highest CAGR from 2023 to 2028”
By type, the clinical decision support systems market is divided into therapeutic CDSS and diagnostic CDSS. The therapeutic CDSS segment dominated this market in 2022 This highest growth rate of this segment can be attributed to factors such as as therapeutic CDSS is equipped with a high computational capacity and a wealth of medical knowledge, making it plausible for clinicians to make informed therapeutic decisions (based on patient-specific medical facts).
“Knowledge-based CDSS segment accounted for the largest share of the global Clinical decision support systems market, by model”
The clinical decision support systems market is categorized into two main models: knowledge-based CDSS and non-knowledge-based CDSS. In 2022, the knowledge-based CDSS segment held the largest market share. This particular segment is projected to experience substantial growth throughout the forecast period. This growth can be attributed to the escalating need for personalized and evidence-based medicine, alongside the growing prevalence of chronic ailments.

“The Active CDSS segment is expected to grow with the highest CAGR during the forecast period”

The clinical decision support systems market can be categorized based on interactivity level into active CDSS and passive CDSS. In 2022, the active CDSS segment dominated the market share, and it is anticipated to exhibit the most rapid growth rate during the forecast period. Strong governmental efforts aimed at fostering clinical IT solutions, including EHR, CDSS, and CPOE, along with the increasing imperative to control healthcare expenditures, contribute to the advancement of this specific market segment.

“Inpatient settings accounted for the largest share of the global Clinical decision support systems market in 2022”
In terms of setting, the clinical decision support systems market is categorized into inpatient and ambulatory care settings. In 2022, the inpatient settings dominated the CDSS market share. This dominance can be attributed to the substantial accumulation and analysis of extensive patient data within inpatient settings, consequently driving the heightened uptake of integrated healthcare IT modules.

“North America to dominate the Clinical decision support systems market in 2023”
North America accounted for the largest share of the global clinical decision support systems market in 2022.
Elements including the existence of major industry participants, regulatory directives that support CDSS adoption, and the rise in medication errors in the US and Canada contribute to these trends.
Forecasts indicate that the Asia Pacific region will witness the most significant compound annual growth rate (CAGR) throughout the projected timeframe. This is due to factors such as the escalating prevalence of chronic illnesses and the growing attention of diverse market stakeholders toward emerging Asian nations. These factors are anticipated to propel the expansion of the clinical decision support systems market in the Asia Pacific region.


Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (45%), Tier 2 (35%), and Tier 3 (20%)
• By Designation: C-level (26%), Director-level (17%), and Others (57%)
• By Region: North America (40%), Europe (20%), Asia Pacific (30%), and Latin America (6%), MEA(4%)

Prominent players operating in the clinical decision support systems market are Wolters Kluwer N.V. (Netherlands), Oracle (US), Merative (US), Change Healthcare (US), Veradigm Inc. (US), athenahealth (US), Epic Systems Corporation (US), Elsevier B.V. (Netherlands), Zynx Health (US), Koninklijke Philips N.V. (Netherlands), Medical Information Technology, Inc. (US), NextGen Healthcare, Inc. (US), CureMD Healthcare (US), Siemens Healthineers (Germany), EBSCO Information Services (US), GE HealthCare (US), eClinicalWorks (US), The Medical Algorithms Company (UK), RAMPmedical (Germany), Hera-MI (France), CareCloud, Inc. (US), VisualDx (US), Premier, Inc. (US), First Databank, Inc. (US), and Strata Decision Technology (US).
Research Coverage
• The report studies the Clinical decision support systems market based on component, delivery mode, product, model, interactivity level, application, setting, type, and region
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders
• The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total Clinical decision support systems market
• The report forecasts the revenue of market segments with respect to four major regions
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
 Analysis of key drivers (implementation of government regulations & initiatives to promote the adoption of HCIT solutions, increasing adoption of cdss-enabled ehrs,growing collaborations & partnerships between stakeholders, growing incidence of medication errors ,development of big data and mhealth tools), restraints (data security concerns related to cloud-based cdss, inadequate interoperability), opportunities (growth potential of emerging markets, social media integration and rising technological advancements), challenges (requirement of high investments for the implementation of CDSS infrastructure ,shortage of skilled IT professionals in the healthcare industry).

• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global Clinical decision support systems Market. The report analyzes this market by component, delivery mode, product, model, interactivity level, application, setting, type.
• Service Enhancement/Innovation: Detailed insights on upcoming trends in the global Clinical decision support systems
• Market Development: Comprehensive information on the lucrative emerging markets by component, delivery mode, product, model, interactivity level, application, setting, type.
• Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global Clinical decision support systems Market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global Clinical decision support systems Market.



ページTOPに戻る


Table of Contents

1 INTRODUCTION 35
1.1 STUDY OBJECTIVES 35
1.2 MARKET DEFINITION 35
1.2.1 INCLUSIONS AND EXCLUSIONS 36
1.3 MARKET SCOPE 37
1.3.1 MARKETS COVERED 37
FIGURE 1 CDSS MARKET SEGMENTATION 37
1.3.2 REGIONS COVERED 37
1.3.3 YEARS CONSIDERED 38
1.4 CURRENCY CONSIDERED 38
1.5 MAJOR STAKEHOLDERS 38
1.6 SUMMARY OF CHANGES 39
1.7 RECESSION IMPACT 39
2 RESEARCH METHODOLOGY 40
2.1 RESEARCH DATA 40
FIGURE 2 RESEARCH DESIGN 40
2.1.1 SECONDARY DATA 41
2.1.1.1 Key data from secondary sources 42
2.1.2 PRIMARY RESEARCH 42
FIGURE 3 PRIMARY SOURCES 43
2.1.2.1 Key data from primary sources 44
2.1.2.2 Key industry insights 44
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 45
2.2 MARKET SIZE ESTIMATION 45
FIGURE 5 HYPOTHESIS BUILDING 46
2.3 MARKET SIZE ESTIMATION METHODOLOGY 46
2.3.1 APPROACH 1: REVENUE SHARE ANALYSIS 46
FIGURE 6 RESEARCH METHODOLOGY: MARKET ESTIMATION 47
2.3.2 APPROACH 2: DEMAND-SIDE ANALYSIS 47
FIGURE 7 APPROACH 2: DEMAND SIDE ANALYSIS 48
2.3.3 APPROACH 3: BOTTOM-UP AND SEGMENTAL EXTRAPOLATION 48
FIGURE 8 APPROACH 3: BOTTOM-UP AND SEGMENTAL EXTRAPOLATION 49
FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50
FIGURE 10 CLINICAL DECISION SUPPORT SYSTEMS MARKET: CAGR PROJECTION ANALYSIS 50
2.4 MARKET DATA ESTIMATION AND TRIANGULATION 52
FIGURE 11 DATA TRIANGULATION METHODOLOGY 52
2.5 STUDY ASSUMPTIONS 53
2.6 RISK ASSESSMENT 54
TABLE 1 RISK ASSESSMENT ANALYSIS 54
2.7 LIMITATIONS 54
2.7.1 SCOPE-RELATED LIMITATIONS 54
2.7.2 METHODOLOGY-RELATED LIMITATIONS 54
2.8 RECESSION IMPACT ANALYSIS 54
3 EXECUTIVE SUMMARY 56
FIGURE 12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2023 VS. 2028 (USD MILLION) 56
FIGURE 13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 57
FIGURE 14 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 57
FIGURE 15 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2023 VS. 2028 (USD MILLION) 58
FIGURE 16 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 59
FIGURE 17 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2023 VS. 2028 (USD MILLION) 59
FIGURE 18 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2023 VS. 2028 (USD MILLION) 60
FIGURE 19 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2023 VS. 2028 (USD MILLION) 61
FIGURE 20 GEOGRAPHICAL SNAPSHOT OF CLINICAL DECISION SUPPORT SYSTEMS MARKET 62
4 PREMIUM INSIGHTS 63
4.1 CLINICAL DECISION SUPPORT SYSTEMS MARKET OVERVIEW 63
FIGURE 21 INCREASING GOVERNMENT REGULATIONS FOR IMPLEMENTATION OF HCIT SOLUTIONS TO DRIVE MARKET 63
4.2 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT AND COUNTRY 64
FIGURE 22 INTEGRATED CDSS SEGMENT DOMINATED US MARKET IN 2022 64
4.3 CLINICAL DECISION SUPPORT SYSTEMS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 64
FIGURE 23 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 64
4.4 CLINICAL DECISION SUPPORT SYSTEMS MARKET: REGIONAL MIX 65
FIGURE 24 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 65
4.5 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DEVELOPED VS. EMERGING ECONOMIES 65
FIGURE 25 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD 65
 
5 MARKET OVERVIEW 66
5.1 INTRODUCTION 66
5.2 MARKET DYNAMICS 66
FIGURE 26 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 66
5.2.1 DRIVERS 67
5.2.1.1 Increasing government regulations for implementation of HCIT solutions 67
5.2.1.2 Growing adoption of CDSS-enabled EHRs 68
5.2.1.3 Rising incidence of medication errors 69
5.2.2 RESTRAINTS 69
5.2.2.1 Data security concerns in cloud-based CDSS 69
5.2.2.2 Inadequate interoperability for patient management solutions 69
5.2.3 OPPORTUNITIES 70
5.2.3.1 Development of big data and mHealth tools 70
5.2.3.2 High growth potential of emerging economies 70
5.2.3.3 Rising technological advancements 71
5.2.4 CHALLENGES 72
5.2.4.1 High capital investments for CDSS infrastructure 72
5.2.4.2 Shortage of skilled IT professionals 72
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 72
FIGURE 27 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR CLINICAL DECISION SUPPORT SYSTEMS MARKET 72
5.4 VALUE CHAIN ANALYSIS 73
FIGURE 28 CLINICAL DECISION SUPPORT SYSTEMS MARKET: VALUE CHAIN ANALYSIS 73
5.5 CASE STUDY ANALYSIS 73
5.5.1 IMPROVING PATIENT OUTCOMES 73
TABLE 2 CASE 1: RISING FOCUS ON IMPROVING PATIENT SAFETY 73
5.5.2 KNOWLEDGE ANALYZER DELIVERS ADVANCED CLINICAL EXPERIENCE 74
TABLE 3 CASE 2: RISING NEED TO STREAMLINE PATIENT OUTCOMES 74
5.5.3 ENHANCING PHYSICIAN EFFICIENCY 74
TABLE 4 CASE 3: RISING NEED TO IMPROVE RESPONSE TIME AND PHYSICIAN EFFICIENCY IN HEALTHCARE FACILITIES 74
5.5.4 INCREASING EFFICIENCY AND HEALTHCARE OUTCOMES WITH AI 75
TABLE 5 CASE 4: RISING FOCUS ON ENHANCING EFFICIENCY AND VALUE-BASED CARE WITH AI-POWERED CDSS 75
5.6 ECOSYSTEM ANALYSIS 75
FIGURE 29 CLINICAL DECISION SUPPORT SYSTEM MARKET: ECOSYSTEM ANALYSIS 75
5.7 TECHNOLOGY ANALYSIS 76
TABLE 6 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS 76
5.8 TARIFF AND REGULATORY ANALYSIS 78
5.8.1 TARIFF FOR CDSS HARDWARE 78
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 7 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 8 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81
TABLE 10 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81
5.8.3 NORTH AMERICA 82
5.8.3.1 Federal Food, Drug, and Cosmetic Act (FD&C Act) 82
5.8.3.2 Health Insurance Portability and Accountability Act (HIPAA) 83
5.8.3.3 Affordable Care Act, 2010 83
5.8.3.4 Health Information Technology for Economic and Clinical Health Act, 2009 (HITECH) 83
5.8.3.5 Consumer Privacy Protection Act, 2017 83
5.8.4 EUROPE 84
5.8.4.1 General Data Protection Regulation (GDPR), European Union (EU) 84
5.8.4.2 EU Cybersecurity Act 84
5.8.5 ASIA PACIFIC 84
5.8.5.1 China’s Cyber Security Law (CSL) 84
5.8.6 REST OF THE WORLD 84
5.8.6.1 Protection of Personal Information Act 84
5.8.6.2 Private cloud computing regulatory framework 84
5.9 PORTER'S FIVE FORCES ANALYSIS 85
TABLE 11 CLINICAL DECISION SUPPORT SYSTEMS MARKET: PORTER’S FIVE FORCES ANALYSIS 85
5.9.1 THREAT OF NEW ENTRANTS 85
5.9.2 THREAT OF SUBSTITUTES 85
5.9.3 BARGAINING POWER OF SUPPLIERS 86
5.9.4 BARGAINING POWER OF BUYERS 86
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 86
5.10 INDUSTRY TRENDS 86
5.10.1 GROWING APPLICATIONS OF AI IN CDSS 86
5.10.2 INCREASING FOCUS ON MOBILE & CLOUD-BASED SOLUTIONS 87
5.10.3 RISING NEED FOR INTEROPERABILITY & INTEGRATION OF HCIT SOLUTIONS 87
5.10.4 GRADUAL SHIFT OF ACCOUNTABILITY FROM PAYERS TO PROVIDERS 88
5.10.5 INCREASING DEMAND FOR VALUE-BASED HEALTHCARE 88
5.11 BUSINESS MODELS 89
FIGURE 30 BENEFITS OF HYBRID BUSINESS MODELS 90
5.12 PRICING ANALYSIS 90
5.12.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT 90
FIGURE 31 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT 91
5.12.2 AVERAGE SELLING PRICE TREND, BY REGION 91
TABLE 12 AVERAGE SELLING PRICE TREND, BY REGION 92
5.13 PATENT ANALYSIS 92
5.13.1 PATENT PUBLICATION TRENDS FOR CLINICAL DECISION SUPPORT SYSTEMS 92
FIGURE 32 PATENT PUBLICATION TRENDS (JANUARY 2011–JUNE 2023) 93
5.13.2 INSIGHTS INTO JURISDICTION AND TOP APPLICANT ANALYSIS 93
FIGURE 33 CLINICAL DECISION SUPPORT SYSTEMS MARKET: TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR PATENTS (JANUARY 2011–AUGUST 2023) 94
5.13.3 LIST OF PATENTS/PATENT APPLICATIONS FOR CDSS 94
5.14 KEY CONFERENCES AND EVENTS 96
TABLE 13 CLINICAL DECISION SUPPORT SYSTEMS: DETAILED LIST OF CONFERENCES AND EVENTS (2023–2024) 96
5.15 TRADE ANALYSIS 96
5.15.1 TRADE ANALYSIS FOR CLINICAL DECISION SUPPORT SYSTEM HARDWARE 96
FIGURE 34 IMPORTS OF PRODUCTS UNDER HSN CODE: 901890, BY COUNTRY, 2022 (USD THOUSAND) 97
FIGURE 35 EXPORTS OF PRODUCTS UNDER HSN CODE: 901890, BY COUNTRY, 2022 (USD THOUSAND) 97
5.16 KEY STAKEHOLDERS AND BUYING CRITERIA 98
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS 98
FIGURE 36 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 98
TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY TYPE (%) 98
5.16.2 BUYING CRITERIA 99
FIGURE 37 CLINICAL DECISION SUPPORT SYSTEMS: KEY BUYING CRITERIA, BY COMPONENT 99
TABLE 15 BUYING CRITERIA FOR COMPONENTS, BY RANK 99
6 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT 100
6.1 INTRODUCTION 101
TABLE 16 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 101
6.2 SERVICES 101
6.2.1 RECURRING REQUIREMENT TO DRIVE MARKET 101
TABLE 17 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 102
6.3 SOFTWARE 103
6.3.1 USE OF EMR-/EHR-INTEGRATED CDSS TO PROPEL MARKET 103
TABLE 18 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION) 103
6.4 HARDWARE 104
6.4.1 FREQUENT UPGRADES FOR OPTIMAL USE TO SUPPORT MARKET GROWTH 104
TABLE 19 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION) 104
7 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT 105
7.1 INTRODUCTION 106
TABLE 20 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 106
7.2 INTEGRATED CDSS 106
7.2.1 INTEGRATION WITH EHRS AND RAPID ACCESS TO PATIENT RECORDS TO DRIVE MARKET 106
TABLE 21 INTEGRATED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 107
7.3 STANDALONE CDSS 108
7.3.1 INTEROPERABILITY ISSUES WITH CPOE AND EHR TO RESTRAIN MARKET 108
TABLE 22 STANDALONE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 108
8 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE 109
8.1 INTRODUCTION 110
TABLE 23 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 110
8.2 THERAPEUTIC CDSS 110
8.2.1 SEAMLESS INTEGRATION INTO CLINICAL WORKFLOWS TO DRIVE MARKET 110
TABLE 24 THERAPEUTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 111
8.3 DIAGNOSTIC CDSS 111
8.3.1 USE OF ALGORITHMS FOR EFFECTIVE REAL-TIME DIAGNOSIS TO SUPPORT MARKET GROWTH 111
TABLE 25 DIAGNOSTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL 113
9.1 INTRODUCTION 114
TABLE 26 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 114
9.2 KNOWLEDGE-BASED CDSS 114
9.2.1 DEPLOYS CONDITIONAL LOGIC FOR DECISION-MAKING AND PROBLEM ANALYSIS 114
TABLE 27 KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115
9.3 NON-KNOWLEDGE-BASED CDSS 115
9.3.1 IMPLEMENTS ML AND AI TO EXPAND USER-DEFINED KNOWLEDGE BASE 115
TABLE 28 NON-KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 116
10 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE 117
10.1 INTRODUCTION 118
TABLE 29 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 118
10.2 ON-PREMISE CDSS 118
10.2.1 LOWER RISK OF DATA BREACH AND ABILITY TO CHOOSE MULTIPLE VENDORS TO DRIVE MARKET 118
TABLE 30 ON-PREMISE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 119
10.3 CLOUD-BASED CDSS 119
10.3.1 FLEXIBLE AND SCALABLE FEATURES TO PROPEL MARKET 119
TABLE 31 CLOUD-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
11 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION 121
11.1 INTRODUCTION 122
TABLE 32 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 122
11.2 CONVENTIONAL CDSS 122
11.2.1 ABILITY TO PROVIDE DIAGNOSTIC ASSISTANCE AND PRESCRIPTION DECISION SUPPORT TO DRIVE MARKET 122
TABLE 33 CONVENTIONAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
11.3 ADVANCED CDSS 123
11.3.1 REAL-TIME EVIDENCE AND PROTOCOL VALIDATION BENEFITS TO PROPEL MARKET 123
TABLE 34 ADVANCED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL 125
12.1 INTRODUCTION 126
TABLE 35 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 126
12.2 ACTIVE CDSS 126
12.2.1 ABILITY TO ENABLE OPTIMAL DECISION-MAKING WITH MINIMAL ERRORS TO DRIVE MARKET 126
TABLE 36 ACTIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 127
12.3 PASSIVE CDSS 127
12.3.1 MINIMAL DISRUPTION TO WORKFLOWS TO SUPPORT MARKET GROWTH 127
TABLE 37 PASSIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 128
13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING 129
13.1 INTRODUCTION 130
TABLE 38 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 130
13.2 INPATIENT SETTINGS 130
13.2.1 GROWING FOCUS ON IMPROVING HEALTHCARE OPERATIONS IN HOSPITALS TO PROPEL MARKET 130
TABLE 39 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR INPATIENT SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION) 131
13.3 AMBULATORY CARE SETTINGS 131
13.3.1 RISING NEED TO CURB HEALTHCARE COSTS TO DRIVE MARKET 131
TABLE 40 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR AMBULATORY CARE SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION) 132
14 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION 133
14.1 INTRODUCTION 134
TABLE 41 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 134
14.2 NORTH AMERICA 134
FIGURE 38 NORTH AMERICA: CDSS MARKET SNAPSHOT 135
TABLE 42 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 43 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 136
TABLE 44 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 136
TABLE 45 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 136
TABLE 46 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 137
TABLE 47 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 137
TABLE 48 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 137
TABLE 49 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 138
TABLE 50 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 138
14.2.1 US 138
14.2.1.1 Growing focus on value-based care to drive market 138
TABLE 51 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 139
TABLE 52 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 140
TABLE 53 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 140
TABLE 54 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 140
TABLE 55 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 141
TABLE 56 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 141
TABLE 57 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 141
TABLE 58 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 142
14.2.2 CANADA 142
14.2.2.1 Rising need to curb healthcare costs to propel market 142
TABLE 59 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 143
TABLE 60 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 143
TABLE 61 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 143
TABLE 62 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 144
TABLE 63 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 144
TABLE 64 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 144
TABLE 65 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 145
TABLE 66 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 145
14.2.3 NORTH AMERICA: RECESSION IMPACT 145
14.3 EUROPE 146
TABLE 67 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 68 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 146
TABLE 69 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 147
TABLE 70 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 147
TABLE 71 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 72 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 148
TABLE 73 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 148
TABLE 74 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 148
TABLE 75 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 149
14.3.1 GERMANY 149
14.3.1.1 Favorable government support for adoption of EMRs to propel market 149
TABLE 76 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 150
TABLE 77 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 150
TABLE 78 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 150
TABLE 79 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 151
TABLE 80 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 151
TABLE 81 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 151
TABLE 82 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 152
TABLE 83 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 152
14.3.2 UK 152
14.3.2.1 Rising establishment of healthcare facilities to fuel market 152
TABLE 84 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 153
TABLE 85 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 153
TABLE 86 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 154
TABLE 87 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 154
TABLE 88 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 154
TABLE 89 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 155
TABLE 90 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 155
TABLE 91 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 155
14.3.3 FRANCE 156
14.3.3.1 Robust interoperability for EHR systems to drive market 156
TABLE 92 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 156
TABLE 93 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 157
TABLE 94 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 157
TABLE 95 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 157
TABLE 96 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 158
TABLE 97 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 158
TABLE 98 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 158
TABLE 99 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 159
14.3.4 ITALY 159
14.3.4.1 Rising need for evidence-based CDSS to drive market 159
TABLE 100 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 159
TABLE 101 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 160
TABLE 102 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 160
TABLE 103 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 160
TABLE 104 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 161
TABLE 105 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 161
TABLE 106 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 161
TABLE 107 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 162
14.3.5 SPAIN 162
14.3.5.1 Growing focus on improving patient outcomes to support market growth 162
TABLE 108 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 162
TABLE 109 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 163
TABLE 110 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 163
TABLE 111 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 112 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 164
TABLE 113 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 164
TABLE 114 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 164
TABLE 115 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 165
14.3.6 REST OF EUROPE 165
TABLE 116 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 165
TABLE 117 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 166
TABLE 118 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 166
TABLE 119 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 166
TABLE 120 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 167
TABLE 121 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 167
TABLE 122 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 167
TABLE 123 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 168
14.3.7 EUROPE: RECESSION IMPACT 168
14.4 ASIA PACIFIC 169
FIGURE 39 ASIA PACIFIC: CDSS MARKET SNAPSHOT 170
TABLE 124 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 125 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 171
TABLE 126 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 171
TABLE 127 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 171
TABLE 128 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 129 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 172
TABLE 130 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 172
TABLE 131 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 173
TABLE 132 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 173
14.4.1 JAPAN 173
14.4.1.1 Rising need to digitize patient records to propel market 173
TABLE 133 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 174
TABLE 134 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 174
TABLE 135 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 174
TABLE 136 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 137 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 175
TABLE 138 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 175
TABLE 139 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 176
TABLE 140 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 176
14.4.2 CHINA 176
14.4.2.1 Established healthcare reforms for EMR solutions to drive market 176
TABLE 141 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 177
TABLE 142 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 177
TABLE 143 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 178
TABLE 144 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 145 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 178
TABLE 146 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 179
TABLE 147 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 179
TABLE 148 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 179
14.4.3 INDIA 180
14.4.3.1 Rising adoption of telemedicine to support market growth 180
TABLE 149 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 180
TABLE 150 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 180
TABLE 151 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 181
TABLE 152 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 153 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 181
TABLE 154 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 182
TABLE 155 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 182
TABLE 156 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 182
14.4.4 REST OF ASIA PACIFIC 183
TABLE 157 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 183
TABLE 158 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 184
TABLE 159 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 184
TABLE 160 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 161 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 185
TABLE 162 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 185
TABLE 163 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 185
TABLE 164 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 186
14.4.5 ASIA PACIFIC: RECESSION IMPACT 186
14.5 REST OF THE WORLD 186
TABLE 165 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 186
TABLE 166 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 187
TABLE 167 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 187
TABLE 168 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 187
TABLE 169 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 170 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 188
TABLE 171 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 188
TABLE 172 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 189
TABLE 173 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 189
14.5.1 LATIN AMERICA 189
14.5.1.1 Developments in healthcare infrastructure to support market growth 189
TABLE 174 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 190
TABLE 175 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 190
TABLE 176 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 190
TABLE 177 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 178 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 191
TABLE 179 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 191
TABLE 180 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 192
TABLE 181 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 192
14.5.2 MIDDLE EAST & AFRICA 192
14.5.2.1 Increasing investments in HCIT solutions to propel market 192
TABLE 182 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 193
TABLE 183 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 193
TABLE 184 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 193
TABLE 185 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 194
TABLE 186 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 194
TABLE 187 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 194
TABLE 188 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 195
TABLE 189 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 195
14.5.3 REST OF THE WORLD: RECESSION IMPACT 195
15 COMPETITIVE LANDSCAPE 196
15.1 OVERVIEW 196
15.2 STRATEGIES ADOPTED BY KEY PLAYERS 196
TABLE 190 CLINICAL DECISION SUPPORT SYSTEMS MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS 197
15.3 REVENUE SHARE ANALYSIS OF LEADING MARKET PLAYERS 198
FIGURE 40 REVENUE SHARE ANALYSIS OF KEY PLAYERS 198
15.4 MARKET SHARE ANALYSIS 199
FIGURE 41 MARKET SHARE ANALYSIS, BY KEY PLAYER (2022) 199
15.5 COMPANY EVALUATION MATRIX 200
15.5.1 STARS 200
15.5.2 EMERGING LEADERS 201
15.5.3 PERVASIVE PLAYERS 201
15.5.4 PARTICIPANTS 201
15.5.5 COMPANY FOOTPRINT 201
TABLE 191 CLINICAL DECISION SUPPORT SYSTEMS MARKET: COMPANY FOOTPRINT OF KEY PLAYERS 201
TABLE 192 CLINICAL DECISION SUPPORT SYSTEMS MARKET: APPLICATION & PRODUCT FOOTPRINT OF KEY PLAYERS 202
TABLE 193 CLINICAL DECISION SUPPORT SYSTEMS MARKET: REGIONAL FOOTPRINT OF KEY PLAYERS 202
FIGURE 42 CLINICAL DECISION SUPPORT SYSTEMS MARKET: COMPANY EVALUATION MATRIX (2022) 203
15.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES 204
15.6.1 PROGRESSIVE COMPANIES 204
15.6.2 RESPONSIVE COMPANIES 204
15.6.3 DYNAMIC COMPANIES 204
15.6.4 STARTING BLOCKS 204
FIGURE 43 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022) 205
15.6.4.1 COMPETITIVE BENCHMARKING 206
TABLE 194 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 206
TABLE 195 CLINICAL DECISION SUPPORT SYSTEMS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (STARTUPS/SMES) 207
15.7 COMPETITIVE SITUATIONS AND TRENDS 207
TABLE 196 CLINICAL DECISION SUPPORT SYSTEMS MARKET: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS (JANUARY 2020–AUGUST 2023) 208
15.7.1 DEALS 210
TABLE 197 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DEALS (JANUARY 2020–AUGUST 2023) 210
15.7.2 OTHER DEVELOPMENTS 212
TABLE 198 CLINICAL DECISION SUPPORT SYSTEMS MARKET: OTHER DEVELOPMENTS (JANUARY 2020–AUGUST 2023) 212

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療/ヘルスケア）の最新刊レポート

MarketsandMarkets社のHealthcare IT分野での最新刊レポート

本レポートと同じKEY WORD（diagnostic）の最新刊レポート


よくあるご質問


MarketsandMarkets社はどのような調査会社ですか?


マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15　10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.